Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Income from Continuing Operations (2024 - 2025)

Beta Bionics' Income from Continuing Operations history spans 2 years, with the latest figure at 13466000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 11.42% year-over-year to 13466000.0; the TTM value through Dec 2025 reached 60749000.0, down 46.94%, while the annual FY2025 figure was 60749000.0, 46.94% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 13466000.0 at Beta Bionics, up from 14210000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 8314000.0 in Q1 2024 and bottomed at 16867000.0 in Q2 2025.